Volume 20, Number 9—September 2014
Enhanced MERS Coronavirus Surveillance of Travelers from the Middle East to England
|Signs and symptoms
||No. MERS CoV–positive/no. tested
|| Positive predictive value, %
|Fever, cough; no pulmonary parenchymal involvement||0/3||0 (0–71†)|
|Fever, cough, and pulmonary parenchymal involvement||2/18||11 (1–35)|
|Fever, cough, and pulmonary parenchymal involvement requiring mechanical ventilation||2/4||50 (7–93)|
|Fever, cough, pulmonary parenchymal involvement, and acute respiratory distress syndrome||2/4||50 (7–93)|
|Fever, cough, and pulmonary parenchymal involvement requiring extracorporeal membrane oxygenation||2/2||100 (16–100)|
*MERS-CoV, Middle East respiratory syndrome coronavirus.
†1-sided, 97.5% CI.